PARK · Park Dental Partners, Inc. · Metrics
$20.56
-0.08 (-0.36%)
At close · Oct 29
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$98.13M
Shares
4.76M
Volume · Oct 29
67.79K
Avg daily vol (3M)
33.43K
PARK metrics
47 of 122 screener metrics currently available.
Market overview
2 metricsShare price
$20.64
Market cap
$98.13M
Price action
20 metricsPrice change (1W)
+3.6%
Price change (30D)
+0.7%
Price change (3M)
+16.8%
Price change (6M)
+16.9%
Price change (YTD)
+39.8%
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
73.9%
Annualized volatility (3M)
51.7%
Beta
0.6
RSI (14D)
55.6
Price vs SMA 50
+1.4%
Price vs SMA 200
+9.0%
Avg volume (3M)
33,433
Relative volume
2.5
Average dollar volume
$683,972
Company
3 metricsSector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
4.76M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
3.1
reciprocal yield 32.5%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
2026-11-13
Last earnings
2026-08-13
Profitability
9 metricsGross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+5.1%
Year over year
Net income growth YoY
-47.5%
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
-84.8%
Shares change YoY
+251.7%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
—
Debt / equity
0.4
Current ratio
1.1
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
1.1
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$13.37M
Latest balance sheet
Cash & equivalents
$24.40M
Total assets
$186.27M
Total debt
$11.03M
Cash flow & spend
7 metricsOperating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
9 metrics13F filers
24
13F filer change QoQ
+4
Institutional ownership
23.2%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
9.4%
Private-fund adviser ownership
9.2%
Active holders' share change QoQ
+24.5%
Holder tenure
2.6
Price vs estimated holder cost
+41.2%
Ownership (registered funds)
1 metricsIndex-fund ownership
1.7%
Short interest
3 metricsShort interest
0.5%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
39 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—